Barron's article says drug could be as high as 450 million in sales some day. Maybe 2014 or 2015. Market value is still over 650 million today. Seems like the stock is well ahead of itself given the state of clinical trials to date.
There really must be a PR tomorrow. They have NOT released one about the results, just announcing the upcoming presentation and what will be covered. Whatever else is discussed is anyone's guess. Chris has been doing things right, and I expect nothing different.